Scholar Rock Holding Corp cotiza a 40.52 USD y tiene una capitalización bursátil de $4.9B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on improving the lives of children and adults with spinal muscular atrophy (SMA) and other rare, severe, and debilitating neuromuscular diseases. The company's novel understanding of the molecular mechanisms of growth factor activation within the tr…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.84 | $-0.83 | $-0.88 |
| Estimado | $-0.84 | $-0.84 | $-0.78 | $-0.88 |
| Sorpresa | — | +0.0% | -6.4% | +0.0% |
| Métrica | SRRK | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | -153.9% | -40.4% | -113.5% |
| ROA | -93.5% | -32.0% | -61.5% |
| Current Ratio | 6.95 | 2.84 | +4.11 |
| Debt / Equity | 0.41 | 0.28 | +0.13 |